Brainstem hemorrhage is presumed to be invariably associated with a poor prognosis in people with spontaneous hypertensive cerebral hemorrhage. The optimal timing of tracheostomy placement in brainstem hemorrhage patients, who generally require endotracheal intubation for airway protection, remains uncertain. Our research aim was to analyze the impact of early tracheostomy versus late tracheostomy on brainstem hemorrhage patients related outcomes and prognostic factors at 30 days. We identified early tracheostomy and how it could benefit the patients with brainstem hemorrhage and ameliorate the predictors of functional recovery at 30 days. Data on 136 patients with brainstem hemorrhage and Glasgow Coma Scale score ≤ 8, were retrospectively collected from 2012 to 2019. Patients were divided into the early tracheostomy group and the late tracheostomy group. Patients in the early tracheostomy group had a significantly lower neurosurgical intensive care unit stay (both overall and survival) compared with the late tracheostomy group (15.6 days vs. 19.0 days, P = 0.041, overall and 14.5 vs. 19.5 days, P = 0.023, survival). Also, the good outcomes (modified Rankin Score ≤ 3) were higher in the early tracheostomy group (P = 0.036). Multivariate analysis demonstrated that less hemorrhagic volume, high Glasgow Coma Scale score on admission, young age, and early tracheostomy were significantly associated with a better 30-day functional outcome. In conclusion, an early tracheostomy in patients with brainstem hemorrhage can reduce neurosurgical intensive care unit stay, and in addition to improvements in prognosis at 30 days.

No abstract

No abstract

No abstract

Objective: To summarize the clinical presentation, diagnosis, and therapy of solitary fibrous tumors (SFT) individuals. Methods: Broad literature research has been conducted as well as the author’s own clinical experienced has been reviewed. Results: Articles from the most recent 30 years have been collected while a typical case of our own has been presented. Based on the most updated evidence, the therapy of SFT has been proposed. Conclusion: For intracranial SFT, it’s rare and similar to common intracranial tumors in imaging examination, the misdiagnosis rate is high. Total surgical resection and postoperative radiotherapy have a certain effect on the prognosis of patients, and gene sequencing can guide the pathological molecular typing of patients and the next step of treatment.